WO1998047914A3 - Us6 gen aus dem humanen cytomegalovirus (hcmv) - Google Patents

Us6 gen aus dem humanen cytomegalovirus (hcmv) Download PDF

Info

Publication number
WO1998047914A3
WO1998047914A3 PCT/EP1998/002225 EP9802225W WO9847914A3 WO 1998047914 A3 WO1998047914 A3 WO 1998047914A3 EP 9802225 W EP9802225 W EP 9802225W WO 9847914 A3 WO9847914 A3 WO 9847914A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene
hcmv
human cytomegalovirus
polypeptide
immunogenicity
Prior art date
Application number
PCT/EP1998/002225
Other languages
English (en)
French (fr)
Other versions
WO1998047914A2 (de
Inventor
Hartmut Hengel
Ulrich Koszinowski
Original Assignee
Boehringer Mannheim Gmbh
Hartmut Hengel
Ulrich Koszinowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh, Hartmut Hengel, Ulrich Koszinowski filed Critical Boehringer Mannheim Gmbh
Priority to AU75262/98A priority Critical patent/AU7526298A/en
Publication of WO1998047914A2 publication Critical patent/WO1998047914A2/de
Publication of WO1998047914A3 publication Critical patent/WO1998047914A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Die Erfindung betrifft das US6 Gen aus dem humanen Cytomegalovirus (HCMV), das davon kodierten Polypeptid, einen gegen das Polypetid gerichteten Antikörper sowie dessen pharmazeutische Anwendungen, insbesondere in der Modulation des Immunsystems und in der Verringung der Immunogenität von transfizierten Zellen.
PCT/EP1998/002225 1997-04-18 1998-04-16 Us6 gen aus dem humanen cytomegalovirus (hcmv) WO1998047914A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU75262/98A AU7526298A (en) 1997-04-18 1998-04-16 Us6 gene from the human cytomegalovirus (hcmv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97106470.4 1997-04-18
EP97106470 1997-04-18

Publications (2)

Publication Number Publication Date
WO1998047914A2 WO1998047914A2 (de) 1998-10-29
WO1998047914A3 true WO1998047914A3 (de) 1999-03-11

Family

ID=8226706

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/002225 WO1998047914A2 (de) 1997-04-18 1998-04-16 Us6 gen aus dem humanen cytomegalovirus (hcmv)

Country Status (2)

Country Link
AU (1) AU7526298A (de)
WO (1) WO1998047914A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2237800T3 (es) * 1996-07-31 2005-08-01 Ortho-Mcneil Pharmaceutical, Inc. Identificacion de genes del citomegalovirus humano implicados en la retro-regulacion de la expresion de las cadenas pesadas de la clase i del cmh.
WO2004031380A1 (ja) * 2002-10-01 2004-04-15 Dnavec Research Inc. TAP活性の阻害により MHC class I による外来エピトープの提示を増強する方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004383A1 (en) * 1994-07-29 1996-02-15 American Cyanamid Company Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression
WO1996031241A1 (en) * 1995-04-04 1996-10-10 Cell Genesys, Inc. Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
WO1998004285A1 (en) * 1996-07-31 1998-02-05 Ortho Pharmaceutical Corporation Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004383A1 (en) * 1994-07-29 1996-02-15 American Cyanamid Company Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression
WO1996031241A1 (en) * 1995-04-04 1996-10-10 Cell Genesys, Inc. Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
WO1998004285A1 (en) * 1996-07-31 1998-02-05 Ortho Pharmaceutical Corporation Identification of human cytomegalovirus genes involved in down-regulation of mhc class i heavy chain expression

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AHN, K. ET AL.: "The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP.", IMMUNITY, (1997 MAY) 6 (5) 613-21, XP002040828 *
GREAVES, R. ET AL.: "SELECTABLE INSERTION AND DELETION MUTAGENESIS OF THE HUMAN CYTOMEGALOVIRUS GENOME USING THE ESCHERICHIA COLI GUANOSINE PHOSPHORIBOSYL TRANSFERASE (GPT) GENE", JOURNAL OF GENERAL VIROLOGY, vol. 76, September 1995 (1995-09-01), pages 2151 - 2160, XP000606695 *
HENGEL, H. ET AL.: "A viral ER-resident glycoprotein inactivates the MHC -encoded peptide transporter.", IMMUNITY, (1997 MAY) 6 (5) 623-32, XP002040827 *
HENGEL, H. ET AL.: "Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly", JOURNAL OF GENERAL VIROLOGY., vol. 77, 1996, READING GB, pages 2287 - 2296, XP002040826 *
LEHNER, P. ET AL.: "The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1997 JUN 24) 94 (13) 6904-9, XP002040829 *
MOMBURG F. ET AL: "The human cytomegalovirus -encoded US6 glycoprotein inhibits the transporter associated with antigen processing.", IMMUNOBIOLOGY, (SEP 1997) 197, PAGE 160, ABSTRACT C.10, XP002079482 *

Also Published As

Publication number Publication date
AU7526298A (en) 1998-11-13
WO1998047914A2 (de) 1998-10-29

Similar Documents

Publication Publication Date Title
WO1999012964A3 (en) Kay - a novel immune system protein
AU9482098A (en) Fusion protein systems
ZA983930B (en) Excitatory amino acid receptor modulators.
EP2272859A3 (de) Immunologische Herpes-Simplex Antigene und Verfahren zu ihrer Verwendung
AU6374598A (en) Transaction system
AU4397297A (en) Antibody against human parathormone related peptides
AUPN999096A0 (en) Peptides, antibodies, vaccines & uses thereof
AU7274898A (en) Recombinant antibody-enzyme fusion proteins
EP1021202A4 (de) Immunogene peptide aus dem hpv e7 protein
AU7706098A (en) Antigen delivery system
AU2809797A (en) Respiration uncoupling protein
AU8620698A (en) Antifreeze proteins, dna and expression systems
AU5906699A (en) (neisseria spp.) polypeptide, nucleic acid sequence and uses thereof
ZA9710243B (en) 3-Amidochromanylsulfonyl(thio)ureas, processes for their preparation, their use, and pharmaceutical preparations comprising them.
AU7072896A (en) Dna encoding medicinal proteins
WO1998047914A3 (de) Us6 gen aus dem humanen cytomegalovirus (hcmv)
AU9269898A (en) Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy
AU5021796A (en) Recombinant human anti-lewis b antibodies
AU6774198A (en) Human rab protein, srab
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
AU6301698A (en) Anti-hiv peptides and proteins
WO1999001475A3 (de) Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist
AU7689298A (en) (nbc), a gene that encodes a member of the bicarbonate transporter family of proteins
AU1693995A (en) Phosphacan, nucleic acids encoding thereof and antibodies thereto
AU9603798A (en) Polymerization catalyst systems, their preparation and use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT GH

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998544968

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA